FDA Investigator Richard Heath Coats
Richard Heath Coats has inspections in 7 countries as of 01 Sep 2023. Richard Heath Coats has collaborated with a combined 2920 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
17
Last Inspection Date:
01 Sep 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America,
Switzerland,
Netherlands,
France,
Australia,
United Kingdom of Great Britain and Northern Ireland,
Korea (Republic of)
Co-Investigator(s):
Alexander M Kay,
Alexey Khrenov, PhD,
Anthony A Charity,
Ashley L Reiber,
Barbara J Holladay,
Barbara Janine Breithaupt,
Barbara M Frazier,
Binh T Nguyen,
Bonita S Chester,
Bradley Dworak, PhD,
Brenda L Reihing,
Brentley S Collins,
Brian D Nicholson,
Bryan Baker,
Burnell M Henry,
Byungja E Marciante,
Carrie Ann Plucinski,
CDR Donald Ertel,
Chaltu N Wakijra,
Charles R Bonapace, PhD,
Christian D Lynch (CDL),
Christine A Harman, PhD,
Christine M Smith,
Christine Mwhitby Smith,
Christopher R Czajka,
Claire M Minden,
Cynthia A Harris, MD, RN,
Cynthia Jim, CSO,
Daniel C Kearns,
Daniel R Azar,
David Perkins,
Deborah M Trout,
Debra Bower,
Debra I Love,
Decarlos A Gomez,
Dennis Cantellops Paite,
Devaughn Edwards,
Deyaa Shaheen,
Dianna D Wardlow Dotter,
Dolores E Price,
Douglas A Campbell,
Dr. Andrew Shroke,
Dr. Mark J Seaton, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Edward D Harris,
Eileen A Liu,
Elena Karnaukhova, PhD,
Eliezar Ramos,
Emest F Bizjak,
Erin L Mcfiren,
Ewa Marszal, PhD,
Francis A Guidry,
Frank W Perrella,
Gabriel M Guevarra,
Gene D Arcy,
Gregory Price,
Helen B Ricalde,
Humera Khan,
Humera T Khan,
Jacqueline Mdiaz Albertini,
James A Jagon,
James D Planchon,
James P Stumpff,
James R Evans,
Jason F Chancey,
Jeanne M Morris,
Jennifer L Schmidt,
Jessica L Walters Moell,
Joan Johnson,
John M Seale,
Jorge L Guadalupe,
Jose Acruz Gonzalez,
Joseph George,
Julie D Bringger,
Jyoti B Patel, PhD,
Kaarin M Slotte,
Katherine E Jacobitz,
Kathryn A Krentz,
Kenneth Nieves,
Kham Phommachanh,
Kimberley A Hoefen,
Kula N Jha,
Kurt A Brorson, PhD,
Lakisha M Williams,
Laura Fontan, MS,
Laurel A Beer,
LCDR Debra Emerson,
LCDR Randall L Morris,
Lynette P Salisbury,
Malgorzata G Norton,
Marisol Faberlle,
Marissa S Steinhagen,
Mariza M Jafary,
Marvin D Jones,
Michael C Kennedy, PhD,
Michael F Skelly, PhD,
Michael R Goga,
Mihaly S Ligmond,
Mra Mcculloughj,
Nancy T Waites,
Nebil A Oumer,
Nicole K Trudel,
Nobuko H Katagiri,
Norman K Starks,
Olga Simakova,
Omotunde O Osunsanmi,
Patrick L Wisor,
Paula A Trost,
Peter Kessler, PhD,
Philip J Snoy,
Prabhu P Raju,
Rachel C Harrington,
Ralph A Erickson,
Raymond W Brullo,
Rebecca K Olin,
Rebecca T Davis,
Reyes Candau Chacon, PhD,
Richard T Riggie,
Robert C Coleman,
Robert D Tollefsen,
Robert L Hummel,
Robert W Jennings,
Rocco C Black,
Roger F Zabinski,
Rose M Ashley,
Russell K Riley,
Samuel W Labinjo,
Sangeeta M Khurana, PhD,
Scott E Norris,
Scott T Ballard,
Sean R Bryd,
Shirley J Berryman,
Sidney B Priesmeyer,
Simone E Pitts,
Sonya L Karsik,
Stephanie L Shapley,
Stephen D Brown,
Stephen R Souza,
Steven C Madzo,
Steven M Weinman,
Steven P Donald,
Susan M Jackson,
Susan P Bruederle,
Susan Yu,
Tamala P Bogan,
Tamala P Magee,
Tania Y Hall,
Tara G Bizjak,
Tara R Gooen,
Terri L Dodds,
Toyin B Oladimeji,
Travis S Bradley,
Unnee Ranjan,
Vanessa Y Gelsey, PhD,
Vanessa Y Jacobs,
Vijaya L Simhadri,
Wayne T Smith,
Wei Wang, PhD,
Xiuju Lu,
Yonggang Wang, PhD,
Zhongren Wu
Richard Heath Coats's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2016 | FDA 483 | SynCo Bio Partners Bv - Form 483, 2016-04-06 |
August, 2013 | FDA 483 | Bioreliance Corporation - Form 483, 2013-08-29 |
July, 2013 | EIR | Stallergenes - EIR, 2013-07-02 |
March, 2019 | FDA 483 | Bavarian Nordic Berna GmbH - Form 483, 2019-03-15 |
July, 2013 | FDA 483 | CENEXI - Form 483, 2013-07-05 |
October, 2015 | FDA 483 | CSL Behring (Australia) Pty Ltd - Form 483, 2015-10-09 |
July, 2013 | FDA 483 | Stallergenes - Form 483, 2013-07-02 |
June, 2016 | FDA 483 | GC Biopharma Corp_Ochang Plant - Form 483, 2016-06-21 |
April, 2014 | EIR | N.V. Organon - EIR, 2014-04-08 |
August, 2013 | EIR | Bioreliance Corporation - EIR, 2013-08-29 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more